Does it excite you to work with model-informed drug development, and do you have experience with planning and executing PK/PD modelling and simulation to innovate clinical development of new drugs in metabolism/obesity? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
Your new position
As Modelling Director in Clinical Pharmacometrics, you will lead the PK/PD modelling and simulation strategy and execution on selected projects in Zealand Pharma’s clinical portfolio. You will partner with clinical, biostatistics, and nonclinical stakeholders to ensure model informed decision making and optimal study design, analyses and communication to support development the next generation of therapies for patients living with obesity.
We offer exciting responsibilities:
- Develop and implement PK/PD models, model-based meta-analyses, and simulations for clinical projects in collaboration with diverse project teams
- Provide model-informed input to clinical development, including trial design, PK/PD sampling strategies, and dose selection
- Serve as PK/PD modelling and simulation expert for internal governance and for external and regulatory interactions for assigned projects
- Manage external collaborations incl. partnerships and CROs to deliver on project objectives
- Contribute to departmental strategy, development of modelling and simulation environment and implementation of innovative methods for high-impact modelling across the portfolio
- Ensure high quality, transparency, and compliance of modelling and simulation deliverables and documentation
Your profile
You thrive in a collaborative, fast-evolving environment and enjoy translating complex model-based evidence into clear recommendations for diverse stakeholders. You combine scientific rigor with a pragmatic, solution-oriented mindset and build strong partnerships across functions to deliver impact for patients.
- PhD in PK/PD modelling or related field with extensive relevant experience in drug development across clinical phases 1–3
- Proficient in NONMEM and R, with strong PK/PD theory and hands-on modelling expertise
- Experienced in communicating model-based results for internal decision-making and external audiences
- Experienced in engaging with health authorities and responding to regulatory queries preferred
- Able to drive innovation and results in collaboration with diverse stakeholders in a complex organization.
- Professional proficiency in English (written and spoken)
Your new team
Our Modelling & Simulation team is growing to match the increasing number of PK/PD modelling and simulation activities in Zealand Pharma from research to development. We deliver QSP, translational PK/PD, pop PK/PD, E-R and MBMA through modelling and simulation in Phoenix, R and NONMEM. We collaborate globally within Zealand Pharma and externally with top experts from our partners including Roche/Genentech and CROs. You will be reporting to the Head of Modelling and Simulation, and will be working closely with your team members, medical and clinical development, biostatistics, and nonclinical colleagues across projects.
Let’s bond and be bold
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other.
We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let’s bond and be bold
Interested in bonding with us? Then please apply no later than November 29, 2025, or as soon as possible. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.
For further information, please contact Head of Modelling and Simulation, Rasmus Juul Kildemoes, +45 5377 9409 or rkildemoes@zealandpharma.com
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a team in the U.S. For more information about Zealand Pharma’s business and activities, please visit www.zealandpharma.com.
